Craig-Hallum initiates Quantinuum coverage with Buy rating, $100 target
Craig-Hallum analyst Richard Shannon initiated coverage on Quantinuum (NASDAQ: QNT) with a Buy rating and a price target of $100. The firm joins other analysts in initiating coverage on various stocks, including Innio NV, Sunshine Silver Mining, Amdocs Ltd, and Solaris Energy Infrastructure.

*this image is generated using AI for illustrative purposes only.
Craig-Hallum analyst Richard Shannon initiated coverage on Quantinuum (NASDAQ: QNT) with a Buy rating and a price target of $100. This rating provides a new investment perspective for market participants, indicating a positive outlook on the company's performance and market position. Quantinuum shares closed at $75.57 on Friday.
Coverage Details
The initiation of coverage by Craig-Hallum adds to the analysis available for Quantinuum. The price target of $100 serves as a benchmark for the stock's potential valuation.
| Metric | Value |
|---|---|
| Rating | Buy |
| Price Target | $100 |
| Analyst | Richard Shannon |
| Coverage Firm | Craig-Hallum |
Other Analyst Initiations
Top Wall Street analysts also initiated coverage on several other names:
- Baird analyst Ben Kallo initiated coverage on Innio NV (NASDAQ: INIO) with an Outperform rating and a price target of $50. Innio shares closed at $37.29 on Friday.
- BMO Capital analyst Kevin O’Halloran initiated coverage on Sunshine Silver Mining And Refining Company (NYSE: SSMR) with an Outperform rating and a price target of $16.5. Sunshine Silver Mining shares closed at $13.42 on Friday.
- Keybanc analyst Devin Au initiated coverage on Amdocs Ltd (NASDAQ: DOX) with a Sector Weight rating. Amdocs shares closed at $51.97 on Friday.
- Needham analyst Sean Milligan initiated coverage on Solaris Energy Infrastructure Inc (NYSE: SEI) with a Buy rating and a price target of $97. Solaris Energy Infrastructure shares closed at $76.80 on Friday.
What specific catalysts does Craig-Hallum anticipate will drive Quantinuum's stock to the $100 price target?
How might this new coverage influence other analysts' ratings on Quantinuum in the near term?
What are the potential risks or challenges Quantinuum could face that could impede reaching the $100 valuation?


























